(AP Photo/Matt Rourke, File ... Analysts see the Keytruda injection as key to buoying Merck's stock, as the company has hit a few headwinds — including slower demand of the HPV vaccine ...

Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...

Cheng Xin / Getty Images Worse-than-expected reports on inflation ... Industries both warned that consumer spending is slowing. Merck anticipates putting an injectable version of its Keytruda ...

Pfizer’s PFE stock hit a new 52-week low of $20.92 on Wednesday but recovered thereafter and closed at $22.49 Though the ...

Facing a global market meltdown, President Donald Trump on Wednesday abruptly backed down on his tariffs on most nations for ...

European Union member states have voted to approve retaliatory tariffs on $23 billion in goods in response to U.S. President ...

Verizon's share price would have to change by 13% to have the same impact on the Dow as a change of just 1% in the price of Goldman stock. Image source: The Motley Fool. The S&P 500 is an index of ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous challenges plaguing the company resulted in the dilution of the stock ...

Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...